The Key to Prostate Cancer
Description
A Guide to Personalized Care. Patients face a real dilemma when selecting among so many treatments with potentially irreversible consequences. Studies show that treatment choices based on partial information often lead to regret.
When initially diagnosed with prostate cancer, the first step is to seek information. Patients struggle to pinpoint correct knowledge amidst a deluge of data overload. The "Paradox of Choice" can be diminished by staging the cancer accurately. The pathway leading out of this confusion is to know your Stage of Blue. With a short, self-administered prostate cancer staging quiz, Key directs readers to targeted information that is stage-specific.
This book directs patients to understand options and educate them about treatments specific for their stage of prostate cancer.
- A short STAGING QUIZ directs patients to their correct stage and which of the seven sections of the book to read.
- The book is divided into seven sections written by experts in prostate cancer. Five of the sections cover the FIVE STAGES OF BLUE.
- The average reader will only need to read three sections: Section I, which covers PSA, Gleason score and body scans, Section VII, which covers lifestyle and general health and only one of the additional sections-one that is related to that patient's prostate cancer stage.
Written by 30 leading experts and edited by a prostate oncologist, Key is a welcome antidote for an industry dominated by surgeons. This book helps patients and doctors work together on a level playing field to intelligently discuss the latest options.
All prices
More details
Person
Content
Preface A Path to Self-Education
Foreword Th e Paradox of Choice
Introduction Synopsis of Treatments
I. Staging and Prognosis
1. Quiz to Assign a Stage of Blue - Peter Scholz
2. Th e PSA Blood Test - Stanley Brosman, MD
3. Interpreting the Pathology Report - Jonathan Epstein, MD
4. Multiparametric MRI and Targeted Biopsy - Daniel Margolis, MD
5. Color Doppler Ultrasound and Targeted Biopsy - Duke Bahn, MD
6. Body Scans and Other Prognostic Factors - Fabio Almeida, MD
7. Picking the Right Doctor - Ralph Blum
II. The Sky Stage of Blue
8. Overview of Sky - Mark Scholz, MD
9. The Science Behind Active Surveillance - Laurence Klotz, MD
10. Focal Cryosurgery - Duke Bahn, MD
11. Introduction to Treatment-Related Side Effects - Mark Scholz, MD
12. Sexual Dysfunction - Kelly Chiles, MD and John Mulhall, MD
13. Surgical Side Effects Affecting Urination - Gary Leach, MD
14. Side Effects from Radiation Therapy - Henry Yampolsky, MD
15. Summary of Sky - Mark Scholz, MD
III. The Teal Stage of Blue
16. Overview of Teal - Mark Scholz, MD
17. Permanent Radioactive Seed Implants - Peter Grimm, DO and John Blasko, MD
18. High-Dose-Rate Seeds - D. Jeffrey Demanes, MD
19. IMRT for Teal - Zachary Zumsteg, MD and Howard Sandler, MD
20. Combination Therapy for Intermediate-Risk - Sean McBride, MD and Michael Zelefsky, MD
21. Proton Beam Therapy - Carl Rossi, MD
22. Stereotactic Body Radiation Therapy (SBRT) - Michael Steinberg, MD
23. TIP Alone as Primary Therapy for Teal - Mark Scholz, MD
24. Robotic Radical Prostatectomy - Timothy Wilson, MD
25. Comparing Treatments for Teal - Mark Scholz, MD
IV. The Azure Stage of Blue
26. Overview of Azure - Mark Scholz, MD
27. Testosterone Inactivating Pharmaceuticals (TIP) - Mark Scholz, MD
28. The Azure Stage of Prostate Cancer - Mark Scholz, MD
29. Unorthodox Therapies for High-Azure - Mark Scholz, MD
30. Reducing the Side Effects of TIP - Mark Scholz, MD
V. The Indigo Stage of Blue
31. Overview of Indigo - Mark Scholz, MD
32. Introduction to Radiation for Indigo - Christopher Rose, MD
33. Indigo-Cancer Relapse or Pelvic Node Disease - Mark Scholz, MD
34. Unorthodox Therapies for Indigo - Mark Scholz, MD
35. Minimizing the Side Effects of Chemotherapy - Richard Lam, MD
36. Indigo-Situations in which PSA is Misleading - Mark Scholz, MD
VI. The Royal Stage of Blue
37. Overview of Royal - Mark Scholz, MD
38. Early Hormonal Resistance: Low-Royal - Mark Scholz, MD
39. Oligometastatic Prostate Cancer: Basic-Royal - Jeffrey Turner, MD
40. Treatments for High-Royal - Richard Lam, MD
41. Unorthodox Therapies for Royal - Mark Scholz, MD
42. Immunotherapy for Prostate Cancer - Charles Drake, MD
43. Genetically Targeted Therapy - Mark Scholz, MD
44. Cancer Research: Striving to Live Longer and Better - Luke Nordquist, MD
45. Pain Management - Mark Scholz, MD
VII. Lifestyle and General Health Issues
46. Health Issues for Men with Prostate Cancer - Jeffrey Turner, MD
47. Whole Nutrition for Prostate Health and Recovery -Verne Varona
48. Fitness and Longevity - Mark Scholz, MD
49. Supplements for Prostate Cancer - Mark Moyad, MD
50. The Key: Knowing Your Stage of Blue - Mark Scholz, MD
